ArticleJournal of clinical and experimental hematopathology : JCEH2025

Brentuximab vedotin monotherapy for CD30-positive adult T-cell leukemia/lymphoma with HTLV-1-infected Hodgkin and Reed-Sternberg-like cells.

Shun Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.